Jonathan Peacock

Jonathan Peacock

Presidente presso UCB

Patrimonio netto: 2 M $ in data 30/06/2026

68 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Jonathan M.
Peacock
was the founder of Arix Bioscience, founded in 2015, where the title held was Non-Executive Director in 2020.
Current jobs include Chairman at UCB SA since 2023, Chairman at BlueSphere Bio, Inc. since 2021, Director at Real Chemistry, Inc. since 2019, Director at Natural History Museum of Los Angeles County, Trustee at Los Angeles County Museum of Natural History, and Vice Chancellor-Health Sciences at the University of California San Diego.
Former jobs include Chairman at Bellerophon Therapeutics, Inc. from 2016 to 2021, Independent Chairman at Avantor, Inc. from 2022 to 2025, Director at Onyx Pharmaceuticals, Inc., Independent Director at Genmab A from 2020 to 2021, Independent Director at Kite Pharma, Inc. from 2014 to 2017, Director at Socati Corp.
from 2019 to 2020, Chief Financial Officer & Executive Vice President at Amgen, Inc. from 2010 to 2014, Partner at PricewaterhouseCoopers LLP from 1993 to 1998, Chief Financial & Administrative Officer at Novartis AG from 2005 to 2010, Partner at McKinsey & Co., Inc. from 1998 to 2005, Chief Financial Officer at Amgen Ventures LLC, Partner at PricewaterhouseCoopers LLP (United Kingdom) from 1993 to 1998, Chief Financial Officer & Executive Vice President at Amgen Rockville, Inc. in 2012, and Chief Financial & Administrative Officer at Novartis Pharmaceuticals AG from 2005 to 2010.
Education includes graduation from the University of St. Andrews in 1981.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
08/05/2025 219.815 ( 0,03% ) 2 M $ 30/06/2026

Posizioni attive di Jonathan Peacock

SocietàPosizioneInizio
UCB Presidente 09/03/2023
Presidente 19/08/2021
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/11/2019
Direttore/Membro del Consiglio -
Corporate Officer/Principal -

Precedenti posizioni note di Jonathan Peacock

SocietàPosizioneFine
AVANTOR, INC. Presidente 31/12/2025
GENMAB A/S Direttore/Membro del Consiglio 15/11/2021
BELLEROPHON THERAPEUTICS, INC. Amministratore Delegato 11/11/2016
░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Jonathan Peacock

Formazione di Jonathan Peacock

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

87

Relazioni di 1° grado

22

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private22

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Commercial Services

Health Technology

Consumer Services

Health Technology

Commercial Services

Novartis Pharmaceuticals AG

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Jonathan Peacock